Related Experiment Video
Updated: May 31, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Subclinical atherosclerosis in menopausal women with low to medium calculated cardiovascular risk
Irene Lambrinoudaki1, Eleni Armeni, Georgios Georgiopoulos
12nd Department of Obstetrics and Gynecology, 76 Vas. Sofias Ave., University of Athens, Aretaieio Hospital, Athens, Greece.
Insights
Subclinical atherosclerosis is common in healthy postmenopausal women, even with low cardiovascular risk scores. Menopausal status and related factors need greater consideration in risk assessments for primary prevention.
Area of Science:
- Cardiology
- Vascular Biology
- Women's Health
Background:
- Cardiovascular disease (CVD) risk stratification systems do not typically include menopausal status.
- Menopause is a known factor associated with increased cardiovascular risk.
Purpose of the Study:
- To assess subclinical vascular disorders in healthy postmenopausal women.
- To evaluate the prevalence of subclinical atherosclerosis in this demographic.
Main Methods:
- Cross-sectional study of 120 healthy postmenopausal women (41-60 years) with low Heartscore (<5%).
- Assessed traditional risk factors, years since menopause, triglycerides, waist circumference, fasting blood glucose, and HOMA-IR.
- Measured carotid-femoral pulse wave velocity and intima-media thickness; presence of atheromatous plaques defined subclinical atherosclerosis.
Main Results:
- Subclinical atherosclerosis was found in 55% of women; 28% had at least one plaque.
- Higher age, years since menopause, HOMA-IR, and blood pressure were associated with subclinical atherosclerosis.
- Years since menopause and systolic blood pressure were independent predictors. 79% of intermediate-risk women (Heartscore 2-4.9%) with menopause ≥4 years were reclassified to higher risk.
Conclusions:
- Subclinical atherosclerosis is highly prevalent in postmenopausal women, even those with low-to-intermediate cardiovascular risk scores.
- Menopausal status and associated factors warrant additional weighting in cardiovascular risk calculations.
- This highlights the need for revised primary prevention strategies for this population.
Background:
The menopausal status is closely related with cardiovascular disease (CVD). Nevertheless, it is still not included in risk stratification by total cardiovascular risk estimation systems. The present study aimed to evaluate the extent of subclinical vascular disorders in young healthy postmenopausal women.
Methods:
This cross-sectional study consecutively recruited 120 healthy postmenopausal women without clinically overt CVD or diabetes, aged 41-60 years and classified as not high-risk by the Heartscore (<5%). In addition to risk factors used for Heartscore calculations, years since menopause and associated risk factors (triglycerides (range 37-278 mg/dl), waist circumference (62-114 cm), fasting blood glucose (69-114 mg/dl) and HOMA-IR (0.44-5)) were also assessed. Carotid-femoral pulse wave velocity, carotid and femoral intima-media thickness in the abnormal range as well as atheromatous plaques both in carotid and femoral arteries were used to define the presence of subclinical atherosclerosis.
Results:
Subclinical atherosclerosis and the presence of at least one plaque were identified in 55% and 28% of women, respectively. Subjects with subclinical atherosclerosis had higher age, years since menopause, HOMA-IR and blood pressure. By multivariate analysis years since menopause and systolic blood pressure independently determined subclinical atherosclerosis while 79% of intermediate-risk women (Heartscore 2-4.9%) being in menopause for at least 4 years would be reclassified to a higher risk for the presence of atherosclerosis.
Conclusion:
Subclinical atherosclerosis was highly prevalent in postmenopausal women with low to medium Heartscore. Thus our data suggest that menopausal status and associated risk factors should be additionally weighted in risk calculations, regarding primary prevention strategies in this population.
Related Concept Videos
Atherosclerosis III: Management
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Coronary Artery Disease IV: Preventive Measures
Atherosclerosis I: Introduction
Atherosclerosis IV: Nursing Management
